Medicare Enrolled
Dr. Noah Lindenberg, MD
Hematology & Oncology · Marlton, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lindenberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lindenberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lindenberg
Dr. Noah Lindenberg is a hematology & oncology specialist in Marlton, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lindenberg performed 292,403 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lindenberg received a total of $9,777 from 93 pharmaceutical and/or device companies across 638 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lindenberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 0% volume in NJ
$9,777 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗292,403
Medicare services
Top 0% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
153,510 | $0 | $7 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
26,400 | $0 | $7 |
| Pembrolizumab injection (Keytruda) | 19,000 | $38 | $71 |
| Paclitaxel chemotherapy injection | 15,400 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 13,020 | $17 | $28 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
12,140 | $6 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
10,650 | $0 | $20 |
| Anti-nausea injection (aprepitant) | 9,880 | $1 | $20 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
9,370 | $0 | $5 |
| Injection, granisetron hydrochloride, 100 mcg | 3,930 | $0 | $10 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
2,472 | $14 | $65 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,340 | $1 | $30 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,920 | $5 | $49 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
1,884 | $89 | $400 |
| Injection, leucovorin calcium, per 50 mg | 1,435 | $3 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,021 | $106 | $295 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
937 | $2 | $25 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
877 | $106 | $390 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
765 | $74 | $200 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
737 | $1 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
588 | $12 | $71 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
473 | $2 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
429 | $56 | $195 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
375 | $101 | $332 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
273 | $26 | $85 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
244 | $58 | $185 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
241 | $25 | $80 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
201 | $18 | $55 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
178 | $1 | $100 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
158 | $2 | $10 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
155 | $147 | $645 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
144 | $17 | $58 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
140 | $50 | $175 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
136 | $3 | $40 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
113 | $113 | $395 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
102 | $29 | $165 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
98 | $8 | $50 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
94 | $11 | $45 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
92 | $30 | $90 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
86 | $1 | $60 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
83 | $1 | $10 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
72 | $0 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
62 | $8 | $25 |
| New patient office visit, complex (60-74 min) | 59 | $187 | $560 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $137 | $445 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
26 | $33 | $165 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $144 | $395 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $92 | $295 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
53.4% high complexity
45.6% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,777
Total received (2018-2024)
Avg $1,397/year across 7 years
Top 28% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
638
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,833
2023
$1,823
2022
$1,618
2021
$1,179
2020
$1,283
2019
$1,122
2018
$919
Payments by company (2024)
Celltrion USA Inc.
$207
Novartis Pharmaceuticals Corporation
$195
Eisai Inc.
$135
PFIZER INC.
$134
AstraZeneca Pharmaceuticals LP
$132
Tempus AI, Inc
$90
ABBVIE INC.
$79
Celgene Corporation
$68
Incyte Corporation
$67
Sumitomo Pharma America, Inc.
$62
Stemline Therapeutics Inc.
$58
EMD Serono, Inc.
$48
Lilly USA, LLC
$43
Takeda Pharmaceuticals U.S.A., Inc.
$41
Daiichi Sankyo Inc.
$39
Pharmacosmos Therapeutics Inc.
$37
GlaxoSmithKline, LLC.
$37
Agios Pharmaceuticals, Inc.
$34
Mirati Therapeutics, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$33
Adaptive Biotechnologies Corporation
$30
Novocure Inc.
$25
Spectrum Pharmaceuticals Inc.
$24
Acrotech Biopharma Inc.
$22
Aveo Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$19
SOBI, INC
$17
Fresenius Kabi USA, LLC
$17
Exelixis Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
Apellis Pharmaceuticals, Inc.
$15
Gilead Sciences, Inc.
$15
Astellas Pharma US Inc
$13
ARRAY BIOPHARMA INC
$10
Top 3 companies account for 29.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$634
PFIZER INC.
$507
Bayer HealthCare Pharmaceuticals Inc.
$482
Incyte Corporation
$458
Celltrion USA Inc.
$410
Janssen Biotech, Inc.
$393
Eisai Inc.
$285
AstraZeneca Pharmaceuticals LP
$281
Amgen Inc.
$280
E.R. Squibb & Sons, L.L.C.
$278
Takeda Pharmaceuticals U.S.A., Inc.
$276
Merck Sharp & Dohme Corporation
$274
Pharmacyclics LLC, An AbbVie Company
$259
Seagen Inc.
$254
GENZYME CORPORATION
$216
Genentech USA, Inc.
$214
Foundation Medicine, Inc.
$194
US Oncology Corporate, Inc.
$168
Lilly USA, LLC
$149
Stemline Therapeutics Inc.
$146
Pharmacosmos Therapeutics Inc.
$138
Exelixis Inc.
$131
Daiichi Sankyo Inc.
$123
Merck Sharp & Dohme LLC
$119
EMD Serono, Inc.
$119
Astellas Pharma US Inc
$117
ABBVIE INC.
$110
GlaxoSmithKline, LLC.
$108
EISAI INC.
$105
AVEO Pharmaceuticals, Inc.
$99
Taiho Oncology, Inc.
$96
Mirati Therapeutics, Inc.
$94
Tempus AI, Inc
$90
Kyowa Kirin, Inc.
$89
Clovis Oncology, Inc.
$85
Celgene Corporation
$82
Dova Pharmaceuticals
$79
Acrotech Biopharma LLC
$77
Adaptive Biotechnologies Corporation
$66
Aurobindo Pharma USA, Inc.
$62
Sumitomo Pharma America, Inc.
$62
Apellis Pharmaceuticals, Inc.
$59
Global Blood Therapeutics, Inc.
$59
Puma Biotechnology, Inc.
$59
Octapharma USA, Inc.
$58
Sun Pharmaceutical Industries Inc.
$55
Kite Pharma, Inc.
$53
AbbVie Inc.
$52
Gilead Sciences, Inc.
$50
TerSera Therapeutics LLC
$49
PUMA BIOTECHNOLOGY, INC.
$46
JAZZ PHARMACEUTICALS INC.
$45
Spectrum Pharmaceuticals Inc.
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Pharmacyclics LLC, an AbbVie Company
$41
ADC Therapeutics America, Inc.
$39
Jazz Pharmaceuticals Inc.
$39
Heron Therapeutics, Inc.
$38
Myovant Sciences Inc.
$38
CTI BioPharma Corp.
$37
Agios Pharmaceuticals, Inc.
$34
SUN PHARMACEUTICAL INDUSTRIES INC.
$34
Immunomedics, Inc.
$34
Mylan Institutional Inc.
$30
AMAG Pharmaceuticals, Inc.
$29
Seattle Genetics, Inc.
$28
Regeneron Healthcare Solutions, Inc.
$27
G1 Therapeutics, Inc.
$26
Novocure Inc.
$25
Rigel Pharmaceuticals, Inc.
$25
ARRAY BIOPHARMA INC
$25
Sirtex Medical Inc
$23
Acrotech Biopharma Inc.
$22
Aveo Pharmaceuticals, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
MACROGENICS, INC.
$18
SOBI, INC
$17
Myriad Genetic Laboratories, Inc.
$17
Fresenius Kabi USA, LLC
$17
SERVIER PHARMACEUTICALS LLC
$16
EUSA Pharma (US) LLC
$15
Cumberland Pharmaceuticals, Inc.
$15
Epizyme, Inc.,
$15
Alexion Pharmaceuticals, Inc.
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Karyopharm Therapeutics Inc.
$15
PharmaEssentia USA Corporation
$14
Coherus Biosciences Inc.
$14
Array BioPharma Inc.
$13
Shire North American Group Inc
$13
Teva Pharmaceuticals USA, Inc.
$13
Fortovia Therapeutics, Inc.
$11
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 16.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fulphila · GAUCHER-DISEASE · GAZYVA · GILOTRIF · HEMADY · HYQVIA · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · Marqibo · Monoferric · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Optune · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · REBLOZYL · RETEVMO · ROLVEDON · Rubraca · SANCUSO · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · Stimufend · Stivarga · Sustol · Sylvant · TAFINLAR · TASIGNA · TAZVERIK · TECENTRIQ · TEPMETKO · TUKYSA · Tavalisse · Trodelvy · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Vitrakvi · Vonjo · XALKORI · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZEVALIN · ZOLADEX · Zevalin · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
230
County median income
$105,271
Nearest hospital to ZIP centroid (approximate)
WEISMAN CHILDRENS REHABILITATION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lindenberg is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lindenberg experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Lindenberg performed 153,510 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lindenberg receive payments from pharmaceutical companies?
Yes. Dr. Lindenberg received a total of $9,777 from 93 companies across 638 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lindenberg's costs compare to other hematology & oncology specialists in Marlton?
Dr. Lindenberg's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lindenberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Marlton
Browse hematology & oncology specialists in Marlton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology